{"transactions":[{"id":714880,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":32079,"kind":"person","name":"BOESS CARSTEN","position":1,"cik":"0001277495","reported_name":"BOESS CARSTEN","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-06T23:59:55.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":64860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 64,860 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 18, 2027."}],"balance_after":64860,"derivative":{"exercise_price":3.35,"expiration_date":"2036-06-18","underlying":"Common Stock","underlying_shares":64860},"source":{"system":"sec-edgar","filing":"0001140361-26-027676","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036126027676/form4.xml","form_type":"4"}},{"id":714879,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":32079,"kind":"person","name":"BOESS CARSTEN","position":1,"cik":"0001277495","reported_name":"BOESS CARSTEN","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-06T23:59:55.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":22862,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units (\"RSUs\") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (\"RSUs\") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2027."}],"balance_after":52862,"source":{"system":"sec-edgar","filing":"0001140361-26-027676","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036126027676/form4.xml","form_type":"4"}},{"id":873714,"issuer":{"id":6185,"kind":"organization","name":"Atrium Therapeutics, Inc.","symbol":"RNA"},"owners":[{"id":32079,"kind":"person","name":"BOESS CARSTEN","position":1,"cik":"0001277495","reported_name":"BOESS CARSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-02T23:00:07.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on February 27, 2026 and the shares underlying the options vest in equal monthly installments over the three years following the grant date, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":14.75,"expiration_date":"2036-02-27","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193125-26-085921","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277495/000119312526085921/ownership.xml","form_type":"4"}},{"id":876929,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":32079,"kind":"person","name":"BOESS CARSTEN","position":1,"cik":"0001277495","reported_name":"BOESS CARSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-27T19:50:19.000Z","date":"2026-02-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20858,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."}],"balance_after":0,"derivative":{"exercise_price":8.82,"expiration_date":"2030-05-14","underlying":"Common Stock","underlying_shares":20858},"source":{"system":"sec-edgar","filing":"0001193125-26-082132","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1277495/000119312526082132/ownership.xml","form_type":"4"}},{"id":876928,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":32079,"kind":"person","name":"BOESS CARSTEN","position":1,"cik":"0001277495","reported_name":"BOESS CARSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-27T19:50:19.000Z","date":"2026-02-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."}],"balance_after":0,"derivative":{"exercise_price":26.09,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193125-26-082132","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1277495/000119312526082132/ownership.xml","form_type":"4"}},{"id":876927,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":32079,"kind":"person","name":"BOESS CARSTEN","position":1,"cik":"0001277495","reported_name":"BOESS CARSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-27T19:50:19.000Z","date":"2026-02-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."}],"balance_after":0,"derivative":{"exercise_price":12.03,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001193125-26-082132","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1277495/000119312526082132/ownership.xml","form_type":"4"}},{"id":876926,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":32079,"kind":"person","name":"BOESS CARSTEN","position":1,"cik":"0001277495","reported_name":"BOESS CARSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-27T19:50:19.000Z","date":"2026-02-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."}],"balance_after":0,"derivative":{"exercise_price":12.48,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001193125-26-082132","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1277495/000119312526082132/ownership.xml","form_type":"4"}},{"id":876925,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":32079,"kind":"person","name":"BOESS CARSTEN","position":1,"cik":"0001277495","reported_name":"BOESS CARSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-27T19:50:19.000Z","date":"2026-02-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":13489,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."}],"balance_after":0,"derivative":{"exercise_price":39.96,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":13489},"source":{"system":"sec-edgar","filing":"0001193125-26-082132","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1277495/000119312526082132/ownership.xml","form_type":"4"}},{"id":876924,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":32079,"kind":"person","name":"BOESS CARSTEN","position":1,"cik":"0001277495","reported_name":"BOESS CARSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-27T19:50:19.000Z","date":"2026-02-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10034,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."}],"balance_after":0,"derivative":{"exercise_price":33.62,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":10034},"source":{"system":"sec-edgar","filing":"0001193125-26-082132","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1277495/000119312526082132/ownership.xml","form_type":"4"}},{"id":876923,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":32079,"kind":"person","name":"BOESS CARSTEN","position":1,"cik":"0001277495","reported_name":"BOESS CARSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-27T19:50:19.000Z","date":"2026-02-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":6692,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities represent shares of Common Stock (inclusive of shares of Common Stock issuable upon settlement of previously reported restricted stock units) disposed of pursuant to the terms of the Agreement and Plan of Merger, dated as of October 25, 2025 (the \"Merger Agreement\"), among Novartis AG (\"Novartis\"), Ajax Acquisition Sub, Inc., an indirect wholly owned subsidiary of Novartis, and the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities represent shares of Common Stock (inclusive of shares of Common Stock issuable upon settlement of previously reported restricted stock units) disposed of pursuant to the terms of the Agreement and Plan of Merger, dated as of October 25, 2025 (the \"Merger Agreement\"), among Novartis AG (\"Novartis\"), Ajax Acquisition Sub, Inc., an indirect wholly owned subsidiary of Novartis, and the Issuer."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-082132","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277495/000119312526082132/ownership.xml","form_type":"4"}},{"id":1084627,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":32079,"kind":"person","name":"BOESS CARSTEN","position":1,"cik":"0001277495","reported_name":"BOESS CARSTEN","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-18T20:05:37.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units (\"RSUs\") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (\"RSUs\") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2026."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001140361-25-026406","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125026406/form4.xml","form_type":"4"}},{"id":1113037,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":32079,"kind":"person","name":"BOESS CARSTEN","position":1,"cik":"0001277495","reported_name":"BOESS CARSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T22:40:46.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":10034,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest in full on the first to occur of June 10, 2026 or the Issuer's 2026 annual meeting of stockholders, in each case subject to the Reporting Person's continuous service to the Issuer through such date."}],"balance_after":10034,"derivative":{"exercise_price":33.62,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":10034},"source":{"system":"sec-edgar","filing":"0001599901-25-000127","document":"wk-form4_1749768039.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1277495/000159990125000127/wk-form4_1749768039.xml","form_type":"4"}},{"id":1113036,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":32079,"kind":"person","name":"BOESS CARSTEN","position":1,"cik":"0001277495","reported_name":"BOESS CARSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T22:40:46.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":6692,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in full on the first to occur of June 10, 2026 or the Issuer's 2026 annual meeting of stockholders, in each case subject to the Reporting Person's continuous service to the Issuer through such date."}],"balance_after":6692,"source":{"system":"sec-edgar","filing":"0001599901-25-000127","document":"wk-form4_1749768039.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277495/000159990125000127/wk-form4_1749768039.xml","form_type":"4"}},{"id":1472987,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":32079,"kind":"person","name":"BOESS CARSTEN","position":1,"cik":"0001277495","reported_name":"BOESS CARSTEN","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-20T20:10:19.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":23944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":". This option represents a right to purchase a total of 23,944 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2025."}],"balance_after":23944,"derivative":{"exercise_price":22.86,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":23944},"source":{"system":"sec-edgar","filing":"0001140361-24-030723","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124030723/form4.xml","form_type":"4"}},{"id":1478701,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":32079,"kind":"person","name":"BOESS CARSTEN","position":1,"cik":"0001277495","reported_name":"BOESS CARSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-14T23:01:27.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":13489,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on the board of directors of the Issuer through such vesting date."}],"balance_after":13489,"derivative":{"exercise_price":39.96,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":13489},"source":{"system":"sec-edgar","filing":"0001599901-24-000095","document":"wk-form4_1718406079.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277495/000159990124000095/wk-form4_1718406079.xml","form_type":"4"}},{"id":1844108,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":32079,"kind":"person","name":"BOESS CARSTEN","position":1,"cik":"0001277495","reported_name":"BOESS CARSTEN","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-26T23:47:54.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":25850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 25,850 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 22, 2024."}],"balance_after":25850,"derivative":{"exercise_price":21.56,"expiration_date":"2033-06-22","underlying":"Common Stock","underlying_shares":25850},"source":{"system":"sec-edgar","filing":"0001140361-23-031528","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123031528/form4.xml","form_type":"4"}},{"id":1849115,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":32079,"kind":"person","name":"BOESS CARSTEN","position":1,"cik":"0001277495","reported_name":"BOESS CARSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-20T20:01:39.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on the board of directors of the Issuer through such vesting date."}],"balance_after":22000,"derivative":{"exercise_price":12.48,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001599901-23-000044","document":"wk-form4_1687291289.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277495/000159990123000044/wk-form4_1687291289.xml","form_type":"4"}},{"id":2227190,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":32079,"kind":"person","name":"BOESS CARSTEN","position":1,"cik":"0001277495","reported_name":"BOESS CARSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-18T00:44:07.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on the board of directors of the Issuer through such vesting date."}],"balance_after":22000,"derivative":{"exercise_price":12.03,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001209191-22-038216","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277495/000120919122038216/doc4.xml","form_type":"4"}},{"id":2231306,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":32079,"kind":"person","name":"BOESS CARSTEN","position":1,"cik":"0001277495","reported_name":"BOESS CARSTEN","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-16T01:07:08.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":47745,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 47,745 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2023."}],"balance_after":47745,"derivative":{"exercise_price":10.77,"expiration_date":"2032-06-13","underlying":"Common Stock","underlying_shares":47745},"source":{"system":"sec-edgar","filing":"0001140361-22-023145","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036122023145/form4.xml","form_type":"4"}},{"id":2666009,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":32079,"kind":"person","name":"BOESS CARSTEN","position":1,"cik":"0001277495","reported_name":"BOESS CARSTEN","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T00:07:25.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":12236,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 12,236 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 14, 2022."}],"balance_after":12236,"derivative":{"exercise_price":47.25,"expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":12236},"source":{"system":"sec-edgar","filing":"0001140361-21-021300","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121021300/form4.xml","form_type":"4"}},{"id":2665847,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":32079,"kind":"person","name":"BOESS CARSTEN","position":1,"cik":"0001277495","reported_name":"BOESS CARSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-16T23:59:54.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on the board of directors of the Issuer through such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":26.09,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-21-041132","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277495/000120919121041132/doc4.xml","form_type":"4"}},{"id":3105281,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":32079,"kind":"person","name":"BOESS CARSTEN","position":1,"cik":"0001277495","reported_name":"BOESS CARSTEN","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-19T01:38:00.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 20,000 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 16, 2021."}],"balance_after":20000,"derivative":{"exercise_price":19.9,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001140361-20-014236","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036120014236/form4.xml","form_type":"4"}},{"id":3682490,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":32079,"kind":"person","name":"BOESS CARSTEN","position":1,"cik":"0001277495","reported_name":"BOESS CARSTEN","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-30T23:38:37.000Z","date":"2019-01-28","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 30,000 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on January 28, 2020."}],"balance_after":30000,"derivative":{"exercise_price":14.56,"expiration_date":"2029-01-28","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001140361-19-002011","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036119002011/form4.xml","form_type":"4"}},{"id":3915653,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":32079,"kind":"person","name":"BOESS CARSTEN","position":1,"cik":"0001277495","reported_name":"BOESS CARSTEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Shares","published_at":"2018-05-29T23:19:09.000Z","date":"2018-05-29","kind":"exercise","acquired":true,"shares":107050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each share of Class B Common Shares is convertible at any time at the election of the holder into one share of Class A Common Shares or one share of Class B1 Common Shares and will automatically convert into Class A Common Shares upon transfer to an unaffiliated party."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of Class B Common Shares is convertible at any time at the election of the holder into one share of Class A Common Shares or one share of Class B1 Common Shares and will automatically convert into Class A Common Shares upon transfer to an unaffiliated party."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of Class B Common Shares is convertible at any time at the election of the holder into one share of Class A Common Shares or one share of Class B1 Common Shares and will automatically convert into Class A Common Shares upon transfer to an unaffiliated party."}],"balance_after":473035,"derivative":{"underlying":"Class A Common Shares","underlying_shares":107050},"source":{"system":"sec-edgar","filing":"0001104659-18-036485","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465918036485/a4.xml","form_type":"4"}},{"id":3915652,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":32079,"kind":"person","name":"BOESS CARSTEN","position":1,"cik":"0001277495","reported_name":"BOESS CARSTEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Shares","published_at":"2018-05-29T23:19:09.000Z","date":"2018-05-29","kind":"exercise","acquired":false,"shares":6392,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon closing of the Issuer's initial public offering, the preferred shares automatically converted into the Issuer's Class A Common Shares on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon closing of the Issuer's initial public offering, the preferred shares automatically converted into the Issuer's Class A Common Shares on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon closing of the Issuer's initial public offering, the preferred shares automatically converted into the Issuer's Class A Common Shares on a one-for-one basis."}],"balance_after":0,"derivative":{"underlying":"Class A Common Shares","underlying_shares":6392},"source":{"system":"sec-edgar","filing":"0001104659-18-036485","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465918036485/a4.xml","form_type":"4"}},{"id":3915651,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":32079,"kind":"person","name":"BOESS CARSTEN","position":1,"cik":"0001277495","reported_name":"BOESS CARSTEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Shares","published_at":"2018-05-29T23:19:09.000Z","date":"2018-05-29","kind":"exercise","acquired":false,"shares":107050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Upon closing of the Issuer's initial public offering, the preferred shares automatically converted into the Issuer's Class B Common Shares on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon closing of the Issuer's initial public offering, the preferred shares automatically converted into the Issuer's Class B Common Shares on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Upon closing of the Issuer's initial public offering, the preferred shares automatically converted into the Issuer's Class B Common Shares on a one-for-one basis."}],"balance_after":0,"derivative":{"underlying":"Class B Common Shares","underlying_shares":107050},"source":{"system":"sec-edgar","filing":"0001104659-18-036485","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465918036485/a4.xml","form_type":"4"}},{"id":3915650,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":32079,"kind":"person","name":"BOESS CARSTEN","position":1,"cik":"0001277495","reported_name":"BOESS CARSTEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Shares","published_at":"2018-05-29T23:19:09.000Z","date":"2018-02-09","kind":"purchase","acquired":true,"shares":6392,"price":15.6438,"value":99995.1696,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon closing of the Issuer's initial public offering, the preferred shares automatically converted into the Issuer's Class A Common Shares on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects the 1-for-2.73235 share consolidation effected May 11, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the 1-for-2.73235 share consolidation effected May 11, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon closing of the Issuer's initial public offering, the preferred shares automatically converted into the Issuer's Class A Common Shares on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon closing of the Issuer's initial public offering, the preferred shares automatically converted into the Issuer's Class A Common Shares on a one-for-one basis."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Reflects the 1-for-2.73235 share consolidation effected May 11, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the 1-for-2.73235 share consolidation effected May 11, 2018."}],"balance_after":6392,"derivative":{"underlying":"Class A Common Shares","underlying_shares":6392},"source":{"system":"sec-edgar","filing":"0001104659-18-036485","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465918036485/a4.xml","form_type":"4"}},{"id":3915649,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":32079,"kind":"person","name":"BOESS CARSTEN","position":1,"cik":"0001277495","reported_name":"BOESS CARSTEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Shares","published_at":"2018-05-29T23:19:09.000Z","date":"2018-05-29","kind":"exercise","acquired":true,"shares":6392,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":79589,"source":{"system":"sec-edgar","filing":"0001104659-18-036485","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465918036485/a4.xml","form_type":"4"}},{"id":3976181,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":32079,"kind":"person","name":"BOESS CARSTEN","position":1,"cik":"0001277495","reported_name":"BOESS CARSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-03T00:13:40.000Z","date":"2018-03-29","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 40,000 shares of the Issuer's Common Stock, 13,336 of which will become fully vested and exercisable on March 29, 2019, with the remaining 26,664 shares vesting in equal monthly installments over the following two years."}],"balance_after":40000,"derivative":{"exercise_price":18.75,"expiration_date":"2028-03-29","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000899243-18-009120","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000089924318009120/doc4.xml","form_type":"4"}},{"id":4275188,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":32079,"kind":"person","name":"BOESS CARSTEN","position":1,"cik":"0001277495","reported_name":"BOESS CARSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2017-06-21T20:07:19.000Z","date":"2017-06-20","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option award was issued pursuant to Inotek Pharmaceuticals Corporation's 2014 Stock Option and Incentive Plan.  The option shall vest in equal quarterly installments at the end of each quarter following June 20, 2017, subject to continued service through such dates."}],"balance_after":45000,"derivative":{"exercise_price":1.8,"expiration_date":"2027-06-19","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0000899243-17-016838","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000089924317016838/doc4.xml","form_type":"4"}}]}